<p>BIT Capital GmbH 在最近向美國證券交易委員會提交的 13F 文件中表示，在第四季度將其在 Oscar Health, Inc. (NYSE:OSCR - 免費報告) 的持股比例提高了 545.0%。該公司在本季度額外購買了 5,227,152 股後，持有該公司 6,186,267 股股票。Oscar Health 佔 BIT Capital GmbH 投資組合的 3.3%，成為其第 12 大持股。根據其最近向美國證券交易委員會提交的文件，BIT Capital GmbH 持有約 2.34% 的 Oscar Health，價值 88,897,000 美元。</p>
<ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
<p>其他幾家對沖基金也對 OSCR 的持倉進行了調整。Quarry LP 在第三季度將其在 Oscar Health 的持倉增加了 439.8%。Quarry LP 目前持有 1,803 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,469 股。Jones Financial Companies Lllp 在第一季度將其在 Oscar Health 的持倉增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股該公司的股票，價值 30,000 美元，此前在上個季度額外購買了 2,242 股。Strs Ohio 在第一季度獲得了 Oscar Health 的新持倉，價值約 30,000 美元。Fifth Third Bancorp 在第四季度將其在 Oscar Health 的持倉增加了 148.7%。Fifth Third Bancorp 目前持有 2,363 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,413 股。最後，Binnacle Investments Inc 在第二季度購買了價值約 75,000 美元的 Oscar Health 股票。當前 75.70% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Oscar Health 關鍵新聞</h2>
<p>以下是本週影響 Oscar Health 的關鍵新聞：</p>
<ul>
<li>積極情緒：富國銀行將 Oscar Health 從 <strong>“強烈賣出” 上調至 “持有”</strong>，儘管其 20 美元的目標價仍低於當前股價，但緩解了看空情緒。Zacks.com</li>
<li>積極情緒：Oscar Health 最近的財報顯示 <strong>大幅超出每股收益預期</strong>，儘管收入低於預期，但支持了該股的基本面故事。</li>
<li>中性情緒：一位公司聯合創始人轉任 <strong>顧問領導角色</strong>，看起來更像是內部重組，而不是顛覆性變化。Oscar Health 聯合創始人轉任顧問領導角色</li>
<li>中性情緒：多位內部人士，包括 <strong>首席財務官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，根據預先計劃的 10b5-1 計劃出售股票，以覆蓋已歸屬股權獎勵的税務義務，這比自願出售的擔憂要小。</li>
<li>消極情緒：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，這是最新一批中最大的一筆內部出售，儘管是預先安排的，但可能會對情緒造成壓力。</li>
</ul>
<h2>Oscar Health 股票表現</h2>
<p>OSCR 週五開盤價為 24.59 美元。該公司的市值為 74.1 億美元，市盈率為 -41.68，市盈增長比率為 1.65，貝塔值為 2.37。該公司的債務與股本比率為 0.26，流動比率為 1.11，速動比率為 1.11。該股票的 50 日簡單移動平均線為 18.39 美元，200 日簡單移動平均線為 16.06 美元。Oscar Health, Inc. 的 1 年最低價為 10.69 美元，1 年最高價為 25.58 美元。</p>
<p>Oscar Health (NYSE:OSCR - 獲取免費報告) 最近於 5 月 6 日發佈了季度財報。該公司報告本季度每股收益為 2.07 美元，超出分析師一致預期的 1.11 美元，超出幅度為 0.96 美元。Oscar Health 的股本回報率為 -3.26%，淨利潤率為 -0.30%。該業務本季度的收入為 46.5 億美元，而分析師預期為 49 億美元。去年同期，該公司每股收益為 0.92 美元。與去年同期相比，該公司的收入增長了 52.6%。整體來看，股票分析師預計 Oscar Health, Inc. 本財年將發佈 0.47 美元的每股收益。</p>
<h2>分析師評級變動</h2>
<p>OSCR 最近成為多份研究報告的主題。Raymond James Financial 將 Oscar Health 的評級從 &#34;市場表現&#34; 上調至 &#34;跑贏大盤&#34;，並在 2 月 12 日的研究報告中設定了 18.00 美元的目標價。Weiss Ratings 在 4 月 21 日的研究報告中重申了對 Oscar Health 股票的 &#34;賣出 (d)&#34; 評級。富國銀行在週四設定了 Oscar Health 的 20.00 美元目標價，並給予該公司 &#34;等權重&#34; 評級。Wall Street Zen 在週六的報告中將 Oscar Health 的評級從 &#34;強力買入&#34; 下調至 &#34;買入&#34;。最後，Zacks Research 在 5 月 7 日的研究報告中將 Oscar Health 的評級從 &#34;持有&#34; 上調至 &#34;強力買入&#34;。一位研究分析師對該股票給予了強力買入評級，兩位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該公司目前的共識評級為 &#34;持有&#34;，共識目標價為 20.22 美元。</p>
<p><strong>查看我們關於 OSCR 的最新報告</strong></p>
<h2>Oscar Health 的內部活動</h2>
<p>在關於 Oscar Health 的其他消息中，首席執行官 Mark T. Bertolini 於 4 月 6 日星期一購買了 1,000,000 股 Oscar Health 股票。每股的平均購買價格為 11.92 美元，總價值為 11,920,000.00 美元。購買後，首席執行官直接持有公司 10,196,876 股，價值為 121,546,761.92 美元。這筆交易代表了其持股比例的 10.87% 的增加。此次收購在向證券交易委員會的法律文件中披露，該文件可在 SEC 網站上查閲。此外，董事 Mario Schlosser 於 6 月 2 日星期二出售了 34,120 股該股票。股票的平均售價為 21.94 美元，總價值為 748,592.80 美元。交易後，該董事直接持有公司 480,866 股，價值約為 10,550,200.04 美元。這代表其持股比例的 6.63% 的減少。此次銷售的 SEC 文件提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。在過去的一個季度中，內部人士已出售 189,660 股公司股票，價值為 4,283,140 美元。公司內部人士持有公司股票的 24.39%。</p>
<h2>關於 Oscar Health</h2>
<p>（免費報告）</p>
<p>Oscar Health 在紐約證券交易所以 OSCR 的股票代碼交易，是一家以技術驅動的健康保險公司，總部位於紐約。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
<p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比 Oscar Health 更好的股票</li>
<li>AI 服務器收益：華爾街看到一個明顯的佼佼者</li>
<li>Navitas：NVIDIA 的 AI 權力經紀人？</li>
<li>Lululemon 的失誤使其股價跌至新低——小心下面</li>
<li>NVIDIA 的新權力遊戲：Fluence 為何在飆升</li>
</ul>
<p><strong>想看看其他對 OSCR 感興趣的對沖基金持有哪些股票？</strong> 訪問 HoldingsChannel.com，獲取 Oscar Health, Inc.（NYSE:OSCR - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
<p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
<p>雖然 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

OSCG

OSCX

<p>BIT Capital GmbH 在第四季度將其在 Oscar Health 的股份增加了 545%，購買了超過 520 萬股。其他機構如 Quarry LP 和 Jones Financial 也顯著增加了他們的持倉。與此同時，富國銀行在每股收益超出預期後將 OSCR 的評級上調至 “持有”，儘管收入未能達到預期。分析師評級各不相同，Raymond James 上調至 “跑贏大盤”，而 Weiss 維持 “賣出” 評級</p>

<p>BIT Capital GmbH lifted its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 545.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,186,267 shares of the company's stock after purchasing an additional 5,227,152 shares during the quarter. Oscar Health comprises 3.3% of BIT Capital GmbH's portfolio, making the stock its 12th biggest holding. BIT Capital GmbH owned about 2.34% of Oscar Health worth $88,897,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>BIT Capital GmbH 在最近向美國證券交易委員會提交的 13F 文件中表示，在第四季度將其在 Oscar Health, Inc. (NYSE:OSCR - 免費報告) 的持股比例提高了 545.0%。該公司在本季度額外購買了 5,227,152 股後，持有該公司 6,186,267 股股票。Oscar Health 佔 BIT Capital GmbH 投資組合的 3.3%，成為其第 12 大持股。根據其最近向美國證券交易委員會提交的文件，BIT Capital GmbH 持有約 2.34% 的 Oscar Health，價值 88,897,000 美元。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
</div><p>Several other hedge funds have also made changes to their positions in OSCR. Quarry LP increased its position in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. Jones Financial Companies Lllp increased its position in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio acquired a new position in Oscar Health during the 1st quarter valued at about $30,000. Fifth Third Bancorp grew its stake in Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock valued at $34,000 after purchasing an additional 1,413 shares during the last quarter. Finally, Binnacle Investments Inc purchased a new stake in shares of Oscar Health in the second quarter worth about $75,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他幾家對沖基金也對 OSCR 的持倉進行了調整。Quarry LP 在第三季度將其在 Oscar Health 的持倉增加了 439.8%。Quarry LP 目前持有 1,803 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,469 股。Jones Financial Companies Lllp 在第一季度將其在 Oscar Health 的持倉增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股該公司的股票，價值 30,000 美元，此前在上個季度額外購買了 2,242 股。Strs Ohio 在第一季度獲得了 Oscar Health 的新持倉，價值約 30,000 美元。Fifth Third Bancorp 在第四季度將其在 Oscar Health 的持倉增加了 148.7%。Fifth Third Bancorp 目前持有 2,363 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,413 股。最後，Binnacle Investments Inc 在第二季度購買了價值約 75,000 美元的 Oscar Health 股票。當前 75.70% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Key Oscar Health News</h2>
<div class="lb-trans"><h2>Oscar Health 關鍵新聞</h2>
</div><p>Here are the key news stories impacting Oscar Health this week:</p>
<div class="lb-trans"><p>以下是本週影響 Oscar Health 的關鍵新聞：</p>
</div><ul>
<li>Positive Sentiment: Wells Fargo upgraded Oscar Health from <strong>“strong sell” to “hold”</strong>, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com</li>
<li>Positive Sentiment: Oscar Health’s recent earnings showed a <strong>major EPS beat</strong>, which supports the stock’s fundamental story despite revenue coming in below estimates.</li>
<li>Neutral Sentiment: A company co-founder shifting into an <strong>advisory leadership role</strong> looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role</li>
<li>Neutral Sentiment: Multiple insiders, including <strong>CFO Richard Scott Blackley</strong> and <strong>CAO Victoria Baltrus</strong>, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.</li>
<li>Negative Sentiment: Director <strong>Mario Schlosser</strong> sold <strong>34,120 shares</strong>, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：富國銀行將 Oscar Health 從 <strong>“強烈賣出” 上調至 “持有”</strong>，儘管其 20 美元的目標價仍低於當前股價，但緩解了看空情緒。Zacks.com</li>
<li>積極情緒：Oscar Health 最近的財報顯示 <strong>大幅超出每股收益預期</strong>，儘管收入低於預期，但支持了該股的基本面故事。</li>
<li>中性情緒：一位公司聯合創始人轉任 <strong>顧問領導角色</strong>，看起來更像是內部重組，而不是顛覆性變化。Oscar Health 聯合創始人轉任顧問領導角色</li>
<li>中性情緒：多位內部人士，包括 <strong>首席財務官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，根據預先計劃的 10b5-1 計劃出售股票，以覆蓋已歸屬股權獎勵的税務義務，這比自願出售的擔憂要小。</li>
<li>消極情緒：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，這是最新一批中最大的一筆內部出售，儘管是預先安排的，但可能會對情緒造成壓力。</li>
</ul>
</div><h2>Oscar Health Stock Performance</h2>
<div class="lb-trans"><h2>Oscar Health 股票表現</h2>
</div><p>OSCR opened at $24.59 on Friday. The stock has a market cap of $7.41 billion, a P/E ratio of -41.68, a P/E/G ratio of 1.65 and a beta of 2.37. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock's 50 day simple moving average is $18.39 and its 200 day simple moving average is $16.06. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $25.58.</p>
<div class="lb-trans"><p>OSCR 週五開盤價為 24.59 美元。該公司的市值為 74.1 億美元，市盈率為 -41.68，市盈增長比率為 1.65，貝塔值為 2.37。該公司的債務與股本比率為 0.26，流動比率為 1.11，速動比率為 1.11。該股票的 50 日簡單移動平均線為 18.39 美元，200 日簡單移動平均線為 16.06 美元。Oscar Health, Inc. 的 1 年最低價為 10.69 美元，1 年最高價為 25.58 美元。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion for the quarter, compared to analysts' expectations of $4.90 billion. During the same quarter in the prior year, the firm posted $0.92 EPS. The company's revenue was up 52.6% compared to the same quarter last year. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health (NYSE:OSCR - 獲取免費報告) 最近於 5 月 6 日發佈了季度財報。該公司報告本季度每股收益為 2.07 美元，超出分析師一致預期的 1.11 美元，超出幅度為 0.96 美元。Oscar Health 的股本回報率為 -3.26%，淨利潤率為 -0.30%。該業務本季度的收入為 46.5 億美元，而分析師預期為 49 億美元。去年同期，該公司每股收益為 0.92 美元。與去年同期相比，該公司的收入增長了 52.6%。整體來看，股票分析師預計 Oscar Health, Inc. 本財年將發佈 0.47 美元的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>OSCR has been the topic of a number of recent research reports. Raymond James Financial upgraded Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Oscar Health in a research report on Tuesday, April 21st. Wells Fargo &amp; Company set a $20.00 price target on Oscar Health and gave the company an &#34;equal weight&#34; rating in a report on Thursday. Wall Street Zen cut Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a report on Saturday. Finally, Zacks Research raised Oscar Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $20.22.</p>
<div class="lb-trans"><p>OSCR 最近成為多份研究報告的主題。Raymond James Financial 將 Oscar Health 的評級從 &#34;市場表現&#34; 上調至 &#34;跑贏大盤&#34;，並在 2 月 12 日的研究報告中設定了 18.00 美元的目標價。Weiss Ratings 在 4 月 21 日的研究報告中重申了對 Oscar Health 股票的 &#34;賣出 (d)&#34; 評級。富國銀行在週四設定了 Oscar Health 的 20.00 美元目標價，並給予該公司 &#34;等權重&#34; 評級。Wall Street Zen 在週六的報告中將 Oscar Health 的評級從 &#34;強力買入&#34; 下調至 &#34;買入&#34;。最後，Zacks Research 在 5 月 7 日的研究報告中將 Oscar Health 的評級從 &#34;持有&#34; 上調至 &#34;強力買入&#34;。一位研究分析師對該股票給予了強力買入評級，兩位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該公司目前的共識評級為 &#34;持有&#34;，共識目標價為 20.22 美元。</p>
</div><p><strong>View Our Latest Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 OSCR 的最新報告</strong></p>
</div><h2>Insider Activity at Oscar Health</h2>
<div class="lb-trans"><h2>Oscar Health 的內部活動</h2>
</div><p>In other Oscar Health news, CEO Mark T. Bertolini purchased 1,000,000 shares of Oscar Health stock in a transaction on Monday, April 6th. The shares were bought at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the purchase, the chief executive officer directly owned 10,196,876 shares in the company, valued at $121,546,761.92. This trade represents a 10.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, Director Mario Schlosser sold 34,120 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $748,592.80. Following the transaction, the director directly owned 480,866 shares in the company, valued at approximately $10,550,200.04. This represents a 6.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 189,660 shares of company stock worth $4,283,140. Company insiders own 24.39% of the company's stock.</p>
<div class="lb-trans"><p>在關於 Oscar Health 的其他消息中，首席執行官 Mark T. Bertolini 於 4 月 6 日星期一購買了 1,000,000 股 Oscar Health 股票。每股的平均購買價格為 11.92 美元，總價值為 11,920,000.00 美元。購買後，首席執行官直接持有公司 10,196,876 股，價值為 121,546,761.92 美元。這筆交易代表了其持股比例的 10.87% 的增加。此次收購在向證券交易委員會的法律文件中披露，該文件可在 SEC 網站上查閲。此外，董事 Mario Schlosser 於 6 月 2 日星期二出售了 34,120 股該股票。股票的平均售價為 21.94 美元，總價值為 748,592.80 美元。交易後，該董事直接持有公司 480,866 股，價值約為 10,550,200.04 美元。這代表其持股比例的 6.63% 的減少。此次銷售的 SEC 文件提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。在過去的一個季度中，內部人士已出售 189,660 股公司股票，價值為 4,283,140 美元。公司內部人士持有公司股票的 24.39%。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>關於 Oscar Health</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health 在紐約證券交易所以 OSCR 的股票代碼交易，是一家以技術驅動的健康保險公司，總部位於紐約。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>AI Server Earnings: Wall Street Sees One Clear Standout</li>
<li>Navitas: NVIDIA’s AI Power Broker?</li>
<li>A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below</li>
<li>NVIDIA's New Power Play: Why Fluence Is Surging</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Oscar Health 更好的股票</li>
<li>AI 服務器收益：華爾街看到一個明顯的佼佼者</li>
<li>Navitas：NVIDIA 的 AI 權力經紀人？</li>
<li>Lululemon 的失誤使其股價跌至新低——小心下面</li>
<li>NVIDIA 的新權力遊戲：Fluence 為何在飆升</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 OSCR 感興趣的對沖基金持有哪些股票？</strong> 訪問 HoldingsChannel.com，獲取 Oscar Health, Inc.（NYSE:OSCR - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

BIT Capital GmbH Purchases 5,227,152 Shares of Oscar Health, Inc. $OSCR

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

五三銀行

富國銀行

瑞傑金融

五三銀行-存託優先股Series K

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

五三銀行-Series A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

BIT Capital GmbH 購買了 5,227,152 股 Oscar Health, Inc.（Oscar Health）的股票